Latest Releases

As the holiday season approaches, it’s a time many associate with joy and togetherness. Yet for millions, it’s a period marked by loneliness. There are things people can do to feel better during this season, Northwestern University experts say.
* Media Advisory

The Black Arts Consortium, Northwestern University’s hub for Black art and cultural exploration, is hosting the first-ever James Baldwin Centennial Symposium, Nov 22 to 24. The three-day forum is dedicated to celebrating the life, work and legacy of the legendary writer and social critic.
* Media Advisory

Northwestern’s Wirtz Center for the Performing Arts kicks off its annual MFA Collaboration series on Friday, Nov. 22 with a gripping drama about four roommates whose Sunday morning drinks lead to explosive revelations. Productions continue into the winter and spring quarters of 2025.

Between 50-75% of people who start taking weight-loss medications like Ozempic or Wegovy — called GLP-1 drugs — stop using them within a year. Northwestern Medicine cardiologist Dr. Sadiya Khan wants to figure out why, what the harms may be of stopping therapy prematurely, and how to help patients continue their therapy.
* Media Advisory

With its ability to improve neuron health, experimental drug NU-9 has already shown promise in reversing amyotrophic lateral sclerosis (ALS). Now, the National Institute on Aging (NIA) has provided approximately $7.3 million to fund exploration into the Northwestern University-invented drug’s effectiveness in other neurodegenerative diseases.

A Northwestern University-led team of engineers has developed a new type of wearable device that stimulates skin to deliver various complex sensations. The thin, flexible device could help people with visual impairments ‘feel’ surroundings.

In an era where demonstrations involving force are growing in number and viewed as a likely source of increased collective violence, the scientific understanding of the correlation between protests and the social media communications of leaders remains debated.

Patients with Huntington’s disease have a genetic mutation that triggers proteins to misfold and clump together in the brain. The new treatment leverages peptide-brush polymers, which act as a shield to prevent proteins from binding to one another.

It’s well established that memory retention in humans follows one of three patterns after the learning period ends: it remains constant, declines or initially improves, then remains constant or declines. A groundbreaking study led by School of Communication researcher Beverly Wright suggests there’s another pattern lesser known in humans called a transient memory lapse. Results of her study challenge conventional wisdom about human memory formation.

For the first time, Northwestern University Library is showcasing dozens of items from the one-of-a-kind Garry Marshall Collection, documenting the life and work of the legendary TV and film writer, director and producer.
* Media Advisory